27613-35-0

Usage

Uses

Used in Organic Synthesis:
Benzonitrile, 4-formyl-2-methyl(9CI) is used as a reagent in organic synthesis for the production of various pharmaceuticals and fine chemicals. Its unique structure allows for versatile reactions and the formation of a wide range of compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Benzonitrile, 4-formyl-2-methyl(9CI) is utilized as a building block for the synthesis of heterocyclic compounds. These heterocyclic compounds are essential components in the development of new drugs with diverse therapeutic properties.
Used in Chemical Research:
Benzonitrile, 4-formyl-2-methyl(9CI) serves as a starting material for the preparation of aromatic aldehydes and acids, which are crucial in chemical research and development. Its ability to form these compounds makes it a valuable resource in advancing scientific knowledge and creating new chemical entities.
Safety Precautions:
As Benzonitrile, 4-formyl-2-methyl(9CI) is classified as a hazardous chemical, it is essential to handle and store it with appropriate safety measures. This includes using personal protective equipment, ensuring proper ventilation, and following established safety protocols to minimize risks associated with its use.

Upstream product

• 557-21-1 zinc(II) cyanide 
• 67832-11-5 4-bromo-2-methylbenzonitrile 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 864731-61-3 A₁₄₄₃ 

Relevant academic research and scientific papers

Fluorine thramine intermediate and method for preparing flumbine by using same

The invention discloses a fluororesonide intermediate and a method for preparing the same, and a fluororesonide intermediate -5. Routes include the use of m-xylene as starting materials, halogenation. Oxidation reaction The intermediate -5 is further obtained by hydroximation, cyanolation, hydrolysis reaction or cyanation, oximation, and hydrolysis reaction. As some examples of the present invention, synthetic routes were increased 2 steps from 5 steps in the prior art, but surprisingly high overall yields were obtained and the purity of intermediate -5 was significantly increased. , The starting material of the intermediate -5 is prepared from high 4 - bromo -2 - methylbenzoic acid to low-priced m-xylene, so that the cost of the intermediate -5 is greatly reduced. , The reaction condition is mild, the synthesis difficulty is low, and the environment is more environmentally friendly.

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

no abstract published

Amine Compounds

There is provided a compound exhibiting an activity of suppressing immune response with reduced adverse drug reactions, which compound is useful in the chemotherapy for preventing or treating, for example, a wide range of various autoimmune diseases including systemic erythematodes, chronic rheumatoid arthritis, Type I diabetes, inflammatory bowel disease, biliary cirrhosis, uveitis, multiple sclerosis or other disorders, or chronic inflammatory diseases, or cancers, lymphoma or leukemia, or resistance to organ or tissue transplantation or rejection against transplantation. Novel amine compounds having an S1P1/Edg1 receptor agonist effect, possible stereoisomers or racemic bodies of the compounds, or pharmacologically acceptable salts, hydrates or solvates of the compound, the stereoisomers or the racemic bodies, or prodrugs of the compounds, the stereoisomers, the racemic bodies, the salts, the hydrates or the solvates, are provided.